Parkinson’s: Patient treated with Deep Brain Stimulation device

In January, the neurosurgical department of the LMU University Hospital in Munich treated the first Parkinson's patient worldwide with a new neurostimulator, which enables better, more personalized care for patients. The new technology can possibly enable stimulation to be adjusted to the treatment requirements of different situations (e.g. walking, speaking, sleeping) and therefore optimize treatment outcome.

Photo
Doctors control the activity of the pacemaker on the tablet.
Source: LMU University Hospital Munich

Even “complex” everyday situations such as talking and walking at the same time should become easier for patients to manage. The neurosurgeons at the LMU University Hospital were also involved in the development of the new technology during clinical studies.

Deep Brain Stimulation (DBS) is delivered through a medical device, similar to a pacemaker, that controls electrodes in the brain and electrically stimulates precisely defined areas. DBS has been used to treat neurological movement disorders for decades. This new generation of THS systems was now first placed in the subthalamic nucleus (STN) of a patient suffering from Parkinson's. The system does not only deliver impulses to the brain, it also features the so-called BrainSense technology that enables the constant recording of patients’ brain signals. These recordings can then be evaluated by a physician to optimize stimulation delivery. Up until now, recordings of this kind were not possible. Treatment plans were optimized based on movement tests carried out in the clinic and - often incomplete - patient records. This new technology allows for brain waves to be continuously recorded, which combined with events recorded by the patient himself (including symptoms or side effects of medication), now enable targeted, personalized and data-controlled neurostimulation.

“DBS is proven to significantly improve motor function in people with Parkinson’s disease compared to standard medication alone and has successfully been used for many years in the treatment of neurological movement disorders,” says PD Dr. Jan H. Mehrkens, Head of Functional Neurology at the LMU Clinic for Neurosurgery in Munich. “Since we were already able to gain experience with the prototype during clinical studies, we have now come full circle in the development of new DBS technologies for Parkinson's patients.” Prof. Dr. Kai Boetzel, LMU clinic for Neurology added: “The new stimulator can measure the activity of the brain’s motor centers and react to it with different stimulation strengths. We will scientifically investigate, whether this ‘feedback stimulation’ is superior to the previous continuous stimulation.”

Parkinson's disease is the second most common disorder of the central nervous system after Alzheimer's disease. Around one percent of the world’s population over the age of 60 is affected. In Germany roughly 400,000 people suffer from it. Parkinson's disease is a slowly progressing condition. Gradually, the death of dopamine-producing nerve cells negatively affects the motor system. Parkinson's itself cannot be healed, therapy focuses on alleviating the symptoms. Treatment typically starts with medication to help reduce movement symptoms by increasing dopamine in the brain or mimicking its effects. When the disease has progressed, there are surgical options that include DBS.

Subscribe to our newsletter

Related articles

Parkinsons: Brain activities wirelessly recorded

Parkinsons: Brain activities wirelessly recorded

Researchers have wirelessly recorded the brain activity of patients living with Parkinson's disease and then used that information to adjust the stimulation delivered by an implanted device.

Virtual reality used in creative arts therapies

Virtual reality used in creative arts therapies

Virtual reality is an emerging as a tool in creative arts therapies. Now, researchers examined the differences in prefrontal cortex activation between two distinct drawing tasks in VR.

Multiple sclerosis: Exoskeleton therapy improves mobility

Multiple sclerosis: Exoskeleton therapy improves mobility

Experts at Kessler Foundation led the first pilot randomized controlled trial of robotic-exoskeleton assisted exercise rehabilitation effects on mobility, cognition, and brain connectivity in people with substantial MS-related disability.

Wearable sensors to track Parkinson's symptoms

Wearable sensors to track Parkinson's symptoms

Scientists have developed algorithms that, combined with wearable sensors, could help clinicians to monitor the progression of Parkinson’s disease.

Soft brain implant controls brain cells​

Soft brain implant controls brain cells​

Researchers have invented a smartphone-controlled soft brain implant that can be recharged wirelessly from outside the body.

Wearable stimulator to zap Alzheimer's disease

Wearable stimulator to zap Alzheimer's disease

Stimulating humans' sense of smell to prevent conditions such as Alzheimer's Disease is the focus of international research.

VR applied to rehabilitation for stroke patients

VR applied to rehabilitation for stroke patients

VR-based rehabilitation programs are becoming an important complement to conventional motor therapy for stroke patients and individuals with neurodegenerative diseases.

A wireless chip shines light on the brain

A wireless chip shines light on the brain

Researchers have developed a chip that is powered wirelessly and can be surgically implanted to read neural signals and stimulate the brain with both light and electrical current.

VR training improves physical and cognitive functions

VR training improves physical and cognitive functions

Researchers have developed an innovative training protocol that, utilizing immersive virtual reality (IVR), leads to real physical and cognitive benefits.

Popular articles

Subscribe to Newsletter